Postpartum testing for antecedent gestational diabetes

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Clinical Diagnostics

Background:

• Gestational diabetes mellitus (GDM) predicts future glucose intolerance in women and their offspring.
• Many women with GDM are not diagnosed, despite signs of hyperglycemia.
• Early detection of GDM is crucial for maternal and infant health.

Purpose of the Study:

• To evaluate the diagnostic accuracy of a postpartum oral glucose tolerance test (oGTT) for detecting antecedent gestational diabetes.
• To compare the utility of postpartum oGTT with cord plasma glucose, cord plasma C-peptide, and neonatal glucose levels.

Main Methods:

• A postpartum (within 48 hours) 100 gm oGTT was administered to women with (n=37) and without (n=28) documented GDM.
• Cord plasma glucose, cord plasma C-peptide, and 2-hour neonatal plasma glucose were measured.
• Receiver operating characteristic (ROC) curve analysis was used to assess diagnostic performance.

Main Results:

• Postpartum oGTT 1-hour, 2-hour, and incremental glucose values showed significant differences between women with and without GDM (p < 0.025).
• Maternal fasting/3-hour glucose, cord plasma glucose/C-peptide, and neonatal glucose did not differ significantly between groups.
• The incremental 1-hour + 2-hour postpartum oGTT demonstrated the best balance of sensitivity and specificity.

Conclusions:

• The incremental 1-hour + 2-hour postpartum oGTT is a valuable tool for identifying women with previous gestational diabetes.
• A threshold of 110 mg/dl for this test achieved 90% specificity and 80% sensitivity.
• This postpartum test can aid in identifying women at risk for future glucose intolerance.